Novo Nordisk

Drug Substance Development and Manufacturing Manager

Novo Nordisk  •  $130k - $165k/yr  •  Boulder, CO (Onsite)  •  2 months ago
Apply
AI can make mistakes so check important info. Chat history is never stored.

Job Description

About the Department

The Boulder Site is home to the specialized technical operations/CMC team for oligonucleotides and RNAi therapeutics. The CMC team works alongside Quality, Regulatory, Technical Operations and RNAi Early Development professionals at our Boulder, Colorado facility and works closely with our teams in Lexington, Massachusetts. Together, we are driving change. Are you ready to make a difference.

The Position

This position is an experienced professional with the ability to support process establishment and manufacturing activities for Novo Nordisk’s oligonucleotide investigational product pipeline. This individual will be responsible for drug substance manufacturing and development at Commercial Manufacturing Organizations (CMO's) and Novo Nordisk internal manufacturing sites.

Relationships

This position reports to the Associate Director of Drug Substance Development and Manufacturing. This position interacts with QA, QC, Internal Chemical Development, Drug Product Manufacturing, Program Management, CMC Regulatory, Manufacturing Operations, and Contract Manufacturing Organizations. This role is based in Boulder, CO

Essential Functions

  • Support establishment and optimization activities developing scalable processes for oligonucleotides. Ensure process strategies developed at laboratory scale can achieve control limits and specifications intended for large scale manufacturing
  • Serve as primary management & technical lead, overseeing CMO activities. Provide guidance for the process development life cycle and how early phase development transitions into commercial manufacturing
  • Support the authoring and review of technical reports and protocols in support of cGMP activities. Serve as the technical expert supporting the development of process characterization protocols. Ensure documents are scientifically sound and conducted within timelines
  • Support the technology transfer and scale up of internally & externally developed platform technologies to partner CMO’s or internal manufacturing
  • Collaborate with cross functional teams for external or internal cGMP manufacturing of drug substance API. Communicate Novo Nordisk manufacturing decisions to CMO’s in a clear, concise, and timely manner
  • Support the review and approval of cGMP batch documentation that ensures manufacturing can achieve the intended process control strategies. Review and approve change controls, in-process control sampling plans, and CAPA’s
  • Perform risk evaluations of manufacturing processes and develop appropriate mitigation plans
  • Coordinate with QA, regulatory, and analytical development to determine documentation for RNAi programs through all phases of product/process development and manufacturing
  • Exercise sound judgement within broadly defined practices and policies in selecting techniques and evaluation criteria for obtaining results

Physical Requirements

Travel required ~4x per year, 2x per year international (Possible). Most travel will be overnight.

Qualifications

  • Bachelor's degree from an accredited university and 4+ years of experience required. Equivalent experience requirements for advanced degrees would be a master’s degree and 2+ years of experience, or a PhD and 0+ years of experience
  • Strong background in oligonucleotide-based drug substance manufacturing process development is highly desired
  • Knowledge of nucleic acids synthesis, purification, annealing techniques and/or analytical development of oligonucleotide analysis methods is highly desired
  • Experience with AKTA 100 and AKTA purification systems is highly desired
  • Thorough understanding of cGxP and applicable regulations, ability to interpret and apply regulations to complex issues to make risk management recommendations
  • Ability to manage people and competing priorities and timelines in a fast-paced, rapid-growth environment

The base compensation range for this position is $130,000 to $165,000. Base compensation is determined based on a number of factors. This position is also eligible for a company bonus based on individual and company performance.

Novo Nordisk offers long-term incentive compensation and or company vehicles depending on the position's level or other company factors.

Employees are also eligible to participate in Company employee benefit programs including medical, dental and vision coverage; life insurance; disability insurance; 401(k) savings plan; flexible spending accounts; employee assistance program; tuition reimbursement program; and voluntary benefits such as group legal, critical illness, identity theft protection, pet insurance and auto/home insurance. The Company also offers time off pursuant to its sick time policy, flex-able vacation policy, and parental leave policy.

The job posting is anticipated to close on April 18, 2026. The Company may however extend this time-period, in which case the posting will remain available on our careers website at www.novonordisk-us/careers.com

We commit to an inclusive recruitment process and equality of opportunity for all our job applicants.

At Novo Nordisk, we're not chasing quick fixes – we're creating lasting change for long-term health. For over 100 years, we've been driven by a single purpose: to defeat serious chronic diseases and help millions of people live healthier lives. This dedication fuels our constant curiosity and inspires us to push the boundaries of what's possible in healthcare. We embrace diverse perspectives, seek out bold ideas, and build partnerships rooted in shared purpose. Together, we're making healthcare more accessible, treating and defeating diseases, and pioneering solutions that create change spanning generations. When you join us, you become part of something bigger – a legacy of impact that reaches far beyond today.

Novo Nordisk is an equal opportunity employer. Qualified applicants will receive consideration for employment without regard to race, ethnicity, color, religion, sex, gender identity, sexual orientation, national origin, disability, protected veteran status or any other characteristic protected by local, state or federal laws, rules or regulations.

If you are interested in applying to Novo Nordisk and need special assistance or an accommodation to apply, please call us at 1-855-411-5290. This contact is for accommodation requests only and cannot be used to inquire about the status of applications.

Novo Nordisk

About Novo Nordisk

We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic disease and create long-term health.

Our unordinary mindset is at the heart of everything we do. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and work to treat, prevent, and even cure diseases that affect millions of lives. Founded in Denmark in 1923, today we employ more than 77,000 people in 80 offices around the world – all united by our bold purpose to drive change to defeat serious chronic diseases. Want to learn more? Visit www.novonordisk.com.

This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to remove those that are off-topic, abusive or intended to spam.

Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in:

https://www.novonordisk.com/contact-us/find-local-information.html

For other customer complaints, please contact us here:

https://www.novonordisk.com/contact-us.html

Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed.

Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users.

Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html

Industry
Chemicals & Materials
Company Size
10,000+ employees
Headquarters
Bagsværd, DK
Year Founded
1923
Social Media